Developing new chemical reactions for creating drug candidates
Sulfur(VI) Fluoride Exchange (SuFEx): new developments and biological applications
This study is all about making new chemical compounds that could help in finding better treatments for diseases, using special techniques to create a variety of small molecules that scientists will test in the lab and possibly in living organisms.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11017726 on NIH RePORTER |
What this research studies
This research focuses on creating innovative sulfur fluoride exchange (SuFEx) reactions to build small-molecule libraries that can be used in drug discovery. By utilizing advanced click chemistry techniques, the project aims to generate diverse chemical structures that may have significant biological applications. The researchers will explore how these new compounds function in laboratory settings and potentially in living organisms, which could lead to the development of new treatments for various diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from bacterial infections or cancers who may benefit from novel therapeutic agents.
Not a fit: Patients with conditions unrelated to bacterial infections or cancers may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new drug candidates that effectively target bacterial infections and cancers.
How similar studies have performed: Other research has shown promise with similar chemical approaches, indicating potential for success in this novel application.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Sharpless, Karl Barry — Scripps Research Institute, the
- Study coordinator: Sharpless, Karl Barry
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.